IM Inj in the deltoid region. Adult & adolescent ≥16 yr2 doses of500 u/mL at 6-12 mth interval. Childn >1 yr but <16 yr2 doses of 250 u/0.5 mL at 6-12 mth interval. Booster dose Preferably given 6-12 mth after 1st dose.
Postpone vaccination in patients w/ acute, severe chronic & chronic diseases at acute attack stage or fever. Patients on anticoagulant therapy. Observe patients for at least 30 min after inj. Medical treatment should be readily available in case of anaphylactic reaction. Pregnancy & lactation.